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(Received for publication, May 9, 1996, and in revised form, July 10, 1996)
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From the Department of Biochemistry, University of Groningen, Nijenborgh 4, 9747 AG Groningen, The Netherlands
Chemoattractants transiently activate guanylyl cy-
clase in Dictyostelium discoideum cells. Mutant analysis
demonstrates that the produced cGMP plays an essen-
tial role in chemotactic signal transduction, controlling
the actomyosin-dependent motive force. Guanylyl cy-
clase activity is associated with the particulate fraction
of a cell homogenate. The addition of the cytosol stimu-
lates guanylyl cyclase activity, whereas the cytosol plus
ATP/Mg21 inhibits enzyme activity. We have analyzed
the regulation of guanylyl cyclase in chemotactic mu-
tants and present evidence that a cGMP-binding protein
mediates both stimulation and ATP-dependent inhibi-
tion of guanylyl cyclase.
Upon chromatography of cytosolic proteins, cGMP
binding activity co-elutes with both guanylyl cyclase-
stimulating and ATP-dependent-inhibiting activities. In
addition, ATP-dependent inhibition of guanylyl cyclase
activity is enhanced by the cGMP analogue 8-Br-cGMP,
suggesting that a cGMP-binding protein regulates gua-
nylyl cyclase activity. Mutant KI-4 has an aberrant
cGMP binding activity with very low Kd and shows a
very small chemoattractant-mediated cGMP response;
the cytosol from this mutant does not stimulate guanylyl
cyclase. In contrast to KI-4, the aberrant cGMP binding
activity of mutant KI-7 has a very high Kd and chemoat-
tractants induce a prolonged cGMP response. The cy-
tosol of this mutant stimulates guanylyl cyclase activity,
but ATP does not inhibit the enzyme. Thus, two previ-
ously isolated chemotactic mutants are defective in the
activation and inhibition of guanylyl cyclase, respec-
tively. The positive and negative regulation of guanylyl
cyclase by its product cGMP may well explain how cells
process the temporospatial information of chemotactic
signals, which is necessary for sensing the direction of
the chemoattractant.
In a number of eukaryotic amoeboid cells, chemotaxis plays
an important role in coordinating cell movement (for review,
see Ref. 1). This simple behavior appears to require a precise
signaling system that transmits the temporospatial gradient of
chemoattractant concentrations to the localized formation of
pseudopodia. Only a 2% difference of chemoattractant concen-
tration between both ends of a Dictyostelium cell is sufficient to
elicit chemotaxis (2). To explore the molecular mechanisms of
chemotaxis in Dictyostelium, both biochemical and genetic ap-
proaches have been used (3).
Dictyostelium grows as amoeboid unicellular cells. On star-
vation, cells start to aggregate by means of chemotactic move-
ment toward cAMP. The chemoattractant cAMP is periodically
secreted at ;5-min intervals by cells from central aggregating
regions. Extracellular cAMP is detected by G-protein-coupled
surface receptors, the binding of which leads to the transient
activation of adenylyl cyclase and guanylyl cyclase (for review,
see Ref. 3). The major role of adenylyl cyclase in chemotaxis is
the propagation of the extracellular cAMP signal through a
population of aggregating cells. Therefore, it is not surprising
that a mutant with a disruption of the adenylyl cyclase gene
shows normal chemotaxis to applied cAMP (4). On the other
hand, many experiments suggest that activation of guanylyl
cyclase is essential for chemotactic signal transduction. The
activation of this enzyme is relatively rapid, resulting in a
7–10-fold increase of intracellular cGMP at 10 s after the ad-
dition of chemoattractant to sensitive cells (5–7). This rapid
increase of cGMP appears to be important for chemotactic
movement. Mutants have been isolated that do not respond to
the chemoattractants cAMP and folic acid. Since a cell detects
these chemoattractants using different surface receptors, it
was expected that the mutations affect components of the sig-
nal transduction cascade that are shared by different chemoat-
tractants. Out of nine of these KI mutants, two mutants were
found that show no cGMP response; mutant KI-8 has no basal
guanylyl cyclase activity, whereas mutant KI-10 has basal
guanylyl cyclase activity that is not stimulated by chemoattrac-
tants (8). Furthermore, characterization of mutants with a
defective cGMP phosphodiesterase, designated as stmF, also
suggests the importance of the cGMP for the processing of
chemotactic signals (9–11).
The actomyosin complex may function as a central system
regulating locomotion during chemotaxis (for review, see Ref.
12). In actomyosin-dependent cell locomotion, assembly of con-
ventional myosin into filaments is required for the effective
interaction with actin fibers, thereby providing optimal motile
force on the plasma membrane (13, 14). The assembly of con-
ventional myosin can be inhibited by phosphorylation of three
threonines in the tail region (15, 16), and as a consequence,
actin-stimulated ATPase activity decreases (17). Analyses of
the non-chemotactic mutants KI-8 and KI-10 and of mutant
stmF indicate that the second messenger cGMP mediates my-
osin phosphorylation. The receptor-stimulated phosphoryla-
tion of conventional myosin was abolished in KI-10 (18) and
KI-8,1 whereas phosphorylation was enhanced in stmF in ac-
cordance with its prolonged cGMP accumulation (19). Further-
more, osmotic stress has been shown to result in the activation
of guanylyl cyclase and phosphorylation of conventional myo-
sin (20). In mutant KI-8, both osmotic stress-mediated re-
sponses are absent, and the cell-permeable cGMP analogue,
8-Br-cGMP, restores osmotic stress-induced myosin phospho-
rylation in KI-8, indicating a connection between cGMP and* The costs of publication of this article were defrayed in part by the
payment of page charges. This article must therefore be hereby marked
“advertisement” in accordance with 18 U.S.C. Section 1734 solely to
indicate this fact.
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myosin phosphorylation (20). For chemotaxis, this could imply
that the local regulation of myosin phosphorylation by cGMP
could be a key mechanism to control the direction of motile
force.
A cGMP-binding protein is expected to accept the cGMP
signal leading to myosin phosphorylation since myosin has no
cGMP binding activity (21). The cytosolic fraction of Dictyoste-
lium lysates contains a cGMP-binding protein with high affin-
ity and specificity (22–24). The binding protein exists in two
conformations, one with relatively low affinity and fast disso-
ciation of the ligand (F-form) and the other with high affinity
and slow dissociation (S-form); DNA promotes the conversion of
the F-form to the S-form (25). The role of this cGMP binding
activity in chemotaxis has long been undetermined. Recently,
however, biochemical analyses of nine non-chemotactic KI-mu-
tants revealed that at least four mutants possess an aberrant
cGMP binding activity, suggesting that this cGMP-binding pro-
tein participates in chemotaxis (26).
We found, unexpectedly, that these non-chemotactic mu-
tants with altered cGMP binding activity also show aberrant
cGMP accumulations in response to cAMP stimulation (8, 26).
The cGMP-binding proteins in mutant KI-4 and KI-5 appear to
be locked in the S-form; these mutants show a very small cGMP
response. On the other hand, the cGMP-binding proteins in
mutants KI-2 and KI-7 show fast dissociation while the che-
moattractant-stimulated cGMP response is prolonged. Genetic
analysis suggests that the two phenotypes, an altered cGMP-
binding protein and an altered cGMP response, are not pro-
vided by multiple mutations (8). These observations provoke
the intriguing hypothesis that in vivo the activity of guanylyl
cyclase is regulated by the target of its product, a cGMP-
binding protein.
It has been observed that magnesium-dependent guanylyl
cyclase is located exclusively in the particulate fraction of a cell
lysate (27, 28) but requires a cytosolic protein for its optimal
activity (29). Furthermore, conditions that promote protein
kinase activity (addition of ATP/Mg21) appear to inhibit gua-
nylyl cyclase activity (30). In this paper, we describe experi-
ments investigating the regulation of guanylyl cyclase by the
cGMP-binding protein in wild type and mutants KI-4 and KI-7.
Our results suggest that the cGMP-binding protein is the factor
that activates guanylyl cyclase. Furthermore, once the cGMP-
binding protein is occupied with cGMP, it inhibits guanylyl
cyclase in an ATP-dependent manner. The importance of this
dual regulation of guanylyl cyclase for the correct processing of
chemotactic signals is suggested by defective regulation in the
chemotactic mutants KI-4 and KI-7. The role of this dual reg-
ulation in maintaining spatial information will be discussed.
EXPERIMENTAL PROCEDURES
Materials—cAMP, cGMP, ADPNHP,2 and GTP were purchased from
Boehringer Mannheim. [8-3H]cGMP (910.2 GBq/mmol) was obtained
from Amersham Corp. Polycarbonate and nitrocellulose filters were
from Nuclepore (Costar, Badhoevedorp, The Netherlands) and
Schleicher & Schuell, respectively. DEAE-Sepharose was obtained from
Pharmacia Biotech Inc.
Strains and Culture Condition—KI-4, KI-7, and the parental strain
XP55 (8) were grown on 1/3 SM plates (0.3% glucose, 0.3% bactopep-
tone, 40 mM KH2PO4/Na2HPO4 buffer, pH 6.0, and 1.5% agar) with
Escherichia coli B/r. Cells were harvested in the late logarithmic phase
with 10 mM KH2PO4/Na2HPO4 buffer, pH 6.5 (PB). Bacteria were
removed by repeated centrifugations at 300 3 g for 3 min. Then cells
were starved for 5 h by shaking in PB at a density of 107 cells/ml at
21 °C.
cGMP Production by cAMP Stimulation—The accumulation of cGMP
on stimulation with 1 mM extracellular cAMP was measured in the
isotope dilution assay as described previously (7).
Cell Lysis and Preparation of the Cytosolic Fraction—The prepara-
tion of a high speed supernatant from cell homogenates was carried out
as described previously with a fewmodifications (26). Starved cells were
resuspended to a density of 2 3 108 cells/ml in cGMP binding assay
buffer (20 mM Hepes/NaOH, 2.2 mM MgSO4, 1 mM EGTA, and 10%
glycerol (v/v), pH 7.5). Cells were then homogenized at 0 °C by passing
the suspension through a polycarbonate filter (pore size of 3 mm). The
homogenate was centrifuged at 4 °C for 1 h at 48,000 3 g. The 48,000 3
g supernatant was used for the cGMP binding experiments, for partial
purification of the cGMP binding activity, and for guanylyl cyclase
reconstitution experiments.
Partial Purification of the cGMP Binding Activity—The prepared
48,000 3 g supernatant from XP55 or KI-4 was subjected to ion-ex-
change chromatography on a 10-ml column of DEAE-Sepharose as
described previously (25). Proteins were eluted from the resin using a
120-ml linear gradient of NaCl (0–400 mM) in cGMP binding assay
buffer. The resulting fractions (1.5 ml) were used in a cGMP binding
assay and in a reconstitution assay with particulate guanylyl cyclase.
All procedures were carried out at 4 °C within 1 day because the
guanylyl cyclase-reconstituting activity and cGMP binding activity are
not very stable (t1⁄2 . 1 day).
cGMP Binding Assay—The cGMP binding activity of the 48,000 3 g
supernatant or the partially purified fractions was measured as de-
scribed previously (23, 25, 26) using 10 nM [3H]cGMP. These binding
assays were performed with or without 100 mg/ml denatured herring
sperm DNA (boiled for 3 min and immediately cooled on ice).
Guanylyl Cyclase Assay—The activity of guanylyl cyclase in total
lysates, particulate fractions, and particulate fractions mixed with cy-
tosolic fractions (reconstituted) was measured as described previously
(29) using a lysis buffer without GTPgS (20 mM Hepes/NaOH, 2.2 mM
MgSO4, and 1 mM EGTA, pH 7.5). Briefly, cells at a density of 10
8
cells/ml in lysis buffer were lysed by rapid elution through a polycar-
bonate filter. When ATP, ADPNHP, or 8-Br-cGMP were present, these
compounds were added to the homogenate immediately after cell lysis.
When azide was present, it was added to the cell suspension 5 min
before lysis.
To prepare a particulate fraction, this cell homogenate was diluted
7-fold in lysis buffer and centrifuged at 14,000 3 g for 1 min at 4 °C. To
determine guanylyl cyclase activity of the particulate fraction, the pel-
let was resuspended to the volume of the original lysate in either fresh
lysis buffer (Fig. 2) or cGMP-binding buffer (Fig. 3). To determine
reconstituted guanylyl cyclase activity, the pellet was resuspended
either in lysis buffer, in the 14,000 3 g supernatant or in partial
purified 48,000 3 g supernatant (see figure legends).
The guanylyl cyclase reaction was started by mixing these prepared
subcellular fractions at 20 °C with an equal volume of reaction mixture
(20 mM Hepes/NaOH, 2.2 mM MgSO4 and 1 mM EGTA, 10 mM dithio-
threitol, 1 mM GTP, pH 7.5); 100 mg/ml denatured herring sperm DNA
was added when indicated. The reactions were terminated after 20, 40,
60, 80, 100, and 120 s by the addition of an equal volume of 3.5% (v/v)
perchloric acid, and the cGMP content was measured in the isotope
dilution assay described above. The NaCl present in the partial purified
supernatant had no detectable influence on guanylyl cyclase activity.
Protein Determination—The protein content of all cell and column
fractions was measured with a Bio-Rad protein assay kit using bovine
serum albumin as a standard.
RESULTS
Activation of Particulate Guanylyl Cyclase Activity by Cyto-
solic Proteins from XP55 and Mutants KI-4 and KI-7—In Dic-
tyostelium wild-type cells, strain NC4, magnesium-dependent
guanylyl cyclase resides in the particulate fraction of a cell
homogenate; the cytosol has no detectable activity but stimu-
lates the activity in the pellet (28, 29). We have investigated
the regulation of guanylyl cyclase in the wild-type XP55 and
the non-chemotactic mutants KI-4 and KI-7. Fig. 1 shows that
guanylyl cyclase activity in the homogenate (T) of XP55 and
mutant KI-7 cells is higher than that in the particulate frac-
tions (P). The re-addition of the cytosolic fraction to the partic-
ulate fraction enhances guanylyl cyclase activity in XP55 and
mutant KI-7 (Fig. 1). The cytosol does not possess guanylyl
cyclase activity (data not shown). These results suggest that
the cytosol derived from both strains possesses a functional
2 The abbreviations used are: ADPNHP, adenosine 59-(b,g-imido)
triphosphate; 8-Br-cGMP, 8-bromoguanosine 39,59-monophosphate;
GTPgS, guanosine 59-3-O-(thio)triphosphate.
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activator of guanylyl cyclase. In contrast to these cell lines,
guanylyl cyclase activities in the homogenate and the particu-
late fraction of mutant KI-4 are essentially identical, and the
re-addition of the cytosolic fraction to the particulate fraction
does not affect enzyme activity (Fig. 1). The differences in
guanylyl cyclase activities between the pellets of these three
strains are much smaller than those between the total homo-
genates, indicating that basal guanylyl cyclase activity is not
affected in the mutants.
To further explore the defect in mutant KI-4, heterologous
reconstitution experiments were performed (Fig. 1, stippled
bars). Guanylyl cyclase in the pellet of XP55 can be stimulated
by the cytosol derived from either wild-type XP55 or mutant
KI-7 but not by the cytosol from mutant KI-4. However, gua-
nylyl cyclase in the pellet of both KI-7 and KI-4 is stimulated by
the cytosol from XP55. These results allow three conclusions: (i)
guanylyl cyclase activity in the particulate fractions of both
mutants is essentially identical to that of the wild type; their
susceptibility to activation by the wild-type cytosolic fraction is
also essentially identical; (ii) the cytosolic activator of mutant
KI-7 shows normal functional properties; and (iii) the cytosol of
mutant KI-4 does not activate the particulate guanylyl cyclase.
Column Chromatography of the Guanylyl Cyclase-stimulat-
ing Activity—The proteins in the cytosol of wild-type XP55
were separated by ion-exchange chromatography. Immediately
after elution of the column, the ability of each fraction to
stimulate particulate guanylyl cyclase from XP55 was tested.
As shown in Fig. 2, the guanylyl cyclase-stimulating activity
eluted as a single peak at approximately 100 mM NaCl in
fraction 41. In the same fractions, we also measured the cGMP
binding activity and observed that the guanylyl cyclase-stimu-
lating activity exactly co-eluted with the cGMP binding activ-
ity. Unfortunately, the guanylyl cyclase-stimulating activity is
not stable (t1⁄2 of approximately 1 day), preventing purification
of the protein. In support of the identity of the cGMP-binding
protein as the guanylyl cyclase-stimulating activity, we ob-
served that both activities showed a similar half-life (data not
shown).
The cytosolic proteins from KI-4 cells were also separated by
ion-exchange chromatography, and guanylyl cyclase-stimulat-
ing activity was tested using the enzyme in the particulate
fraction of XP55. A large peak of cGMP binding activity was
eluted from the column; however, none of the fractions could
stimulate guanylyl cyclase activity (Fig. 2B). This result shows
that KI-4 has the cGMP-binding protein but lacks guanylyl
cyclase-stimulating activity.
Effect of DNA on cGMP Binding Activity and Guanylyl Cy-
clase Activation—DNA fragments strongly enhance the bind-
ing of cGMP to the cGMP-binding protein (25, 26). The effect of
DNA on the cGMP binding activity and on guanylyl cyclase-
stimulating activity was tested in the wild type and in the KI
mutants. As shown in Fig. 3A, denatured herring DNA en-
FIG. 1. Guanylyl cyclase activity in cell homogenates (T), par-
ticulate fractions (P), and in reconstituted mixtures of particu-
late and cytosolic fractions (P 1 S) from the wild-type strain
XP55 and mutants KI-4 and KI-7. Cell homogenates and particulate
and cytosolic fractions were prepared as described under “Experimental
Procedures.” The particulate fraction was resuspended in the original
volume with buffer or with the cytosolic fraction from the strain indi-
cated. Guanylyl cyclase activity is expressed as picomoles of cGMP
formed per min per mg of protein present in the original homogenate
from which the particulate fraction was obtained. Data are the means 6
S.D. of two independent experiments with triplicate determinations.
FIG. 2. Ion-exchange chromatography of the cGMP binding
activity and guanylyl cyclase-stimulating activity from the cy-
tosolic fraction of the parental strain XP55 (A) and KI-4 (B). The
high speed supernatant obtained upon centrifugation of a homogenate
at 48,000 3 g was loaded on a DEAE-Sepharose column. Proteins were
eluted by means of a linear NaCl gradient (0–400 mM in 120 ml of
cGMP binding assay buffer; dotted line). The cGMP binding activity and
the ability to activate the particulate guanylyl cyclase from XP55 were
determined for each fraction as described under “Experimental Proce-
dures.” The activity is expressed as picomoles of cGMP formed per min
per mg of protein present in the original homogenate from which the
particulate fraction was obtained. The data are from a representative
experiment repeated twice (XP55) or once (KI-4).
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hances cGMP binding activity in the cytosol of wild-type XP55
and mutant KI-7, but has no effect on the cGMP binding
activity from mutant KI-4. The addition of DNA causes a dra-
matic increase of guanylyl cyclase activity in the homogenates
of XP55 and KI-7 (Fig. 3B). In accordance with the lack of effect
of DNA on cGMP binding, DNA fragments do not alter guanylyl
cyclase activity in KI-4 homogenates.
To summarize the previous experiments, we obtained evi-
dence supporting the hypothesis that the cGMP-binding pro-
tein is identical to the cytosolic activator of particulate gua-
nylyl cyclase and that the aberrant cGMP-binding protein in
KI-4 lacks the functional effect to stimulate guanylyl cyclase.
Although the cGMP binding activity of mutant KI-7 is not
completely normal, the cytosol from this mutant stimulates
particulate guanylyl cyclase in a manner that is indistinguish-
able from that of wild-type cells.
In the next series of experiments, we pursue the observation
by Schoen (30) that conditions favoring protein phosphoryla-
tion lead to inhibition of guanylyl cyclase and investigate the
hypothesis that the cGMP-binding protein again mediates this
effect.
Reduction of Guanylyl Cyclase Activity by Enhancement of
Protein Kinase Activity—Previously, it was shown that en-
hancement of protein kinase activity by adding ATP/Mg21 re-
sulted in reduced guanylyl cyclase activity (30), and conversely,
inhibition of protein kinase activity by the protein kinase in-
hibitor ADPNHP increased guanylyl cyclase activity in cell
homogenates from wild-type cells (27, 28).
Fig. 4 shows that the observations mentioned above are
reproduced for the wild-type XP55; 1 mM ATP strongly reduces
guanylyl cyclase activity whereas 0.1 mM ADPNHP enhances
guanylyl cyclase activity. Because the concentration of ATP in
the cell homogenate is estimated to be about 10 mM, which may
already partly inhibit guanylyl cyclase, the homogenate was
prepared from cells treated with 10 mM azide for 5 min, which
is expected to reduce the intracellular ATP concentration 10-
fold (31). Pretreatment with azide leads to a significant in-
crease of guanylyl cyclase activity to nearly the same level as
that in the presence of ADPNHP.
Guanylyl cyclase activity from KI-4 is not altered by the
addition of ATP or ADPNHP or by the pretreatment of the cells
with azide (Fig. 4). Guanylyl cyclase activity in the homogenate
of KI-4 is low because the enzyme is not activated by the
cytosolic factor. Guanylyl cyclase activity of mutant KI-7,
which is relatively high due to its activation by the cytosolic
factor, is also not affected by ATP, ADPNHP, or azide treat-
ment. Furthermore, ATP, ADPNHP, and azide treatment have
no effect on guanylyl cyclase activity of the particulate fraction
from wild-type XP55 (Fig. 5). ATP-dependent inhibition of gua-
nylyl cyclase can be reconstituted by adding the cytosolic frac-
tion, indicating that inhibition acts via a cytosolic factor (data
not shown). The cytosol was chromatographed as described in
Fig. 2A, and the fractions were reconstituted with the particu-
late fraction from azide-treated XP55 cells. ATP-dependent
inhibition of guanylyl cyclase was observed only when the
enzyme was supplemented with column fractions eluting at
100 mM NaCl (Fig. 5). These are exactly the same fractions that
stimulate guanylyl cyclase in the absence of ATP.
The Effect of a cGMP Analogue on Stimulation and ATP-
dependent Inhibition of Guanylyl Cyclase—The previous sec-
tions suggest that the soluble cGMP-binding protein may acti-
vate guanylyl cyclase and that this stimulation is lost by ATP-
dependent inhibition of particulate guanylyl cyclase. In the last
section, we investigate whether occupancy of this binding pro-
tein with cGMP modulates these stimulatory and inhibitory
effects. The cGMP analog 8-Br-cGMP was used since it has a
high affinity for the cGMP-binding protein but does not
strongly interfere with the determination of cGMP levels in
isotope dilution assay. The experiments have some intrinsic
problems since the reaction product cGMP may also bind to the
binding protein. Furthermore, the GTP that is present as sub-
strate may be converted to ATP by nucleoside diphosphate
kinase present in the cytosol and pellet (32), which then acts as
an inhibitor of guanylyl cyclase. Finally, modulation of gua-
nylyl cyclase activity by ATP and 8-Br-cGMP may not be in-
stantaneous. These collective difficulties were anticipated by
measuring guanylyl cyclase between 20 and 120 s after the
onset of the reaction, during which time minimal amounts of
ATP and cGMP are formed from GTP.
The addition of 50 nM 8-Br-cGMP to the particulate fraction
has no effect on basal guanylyl cyclase activity, either in the
absence or presence of 1 mM ATP (Fig. 5). The cytosol (see total
homogenate in figure) or the partially purified cGMP-binding
protein stimulates particulate guanylyl cyclase activity as
shown before; the occupancy of the cGMP-binding protein with
8-Br-cGMP has no additional effects on guanylyl cyclase activ-
ity (Fig. 5). ATP inhibits guanylyl cyclase activity in the homo-
genate or when it is reconstituted from the particulate and
the partially purified cytosolic fraction. The addition of 50 nM
8-Br-cGMP significantly potentiates this ATP-mediated inhibi-
tion (Fig. 5). These combined results suggest that cGMP does
not participate in the activation of guanylyl cyclase, or in other
words, the guanylyl cyclase is stimulated by the cGMP-binding
protein whether it is occupied with cGMP or not. On the other
hand, ATP-mediated inhibition of guanylyl cyclase by the
cGMP-binding protein is potentiated by cGMP.
FIG. 3. Effect of DNA fragments on cGMP binding activity (A)
and guanylyl cyclase activity (B) in cell homogenates of XP55,
KI-4, and KI-7. cGMP binding activity and guanylyl cyclase activity
were measured as described under “Experimental Procedures.” Assays
were performed in the absence or presence of 100 mg/ml denatured
herring sperm DNA. Data are the means 6 S.D. of two independent
experiments with triplicate determinations. *, significantly different
from control without DNA (p , 0.01).
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Activation of guanylyl cyclase by extracellular signal mole-
cules is an important intracellular signaling pathway in many
biological systems. In Dictyostelium discoideum, mutant anal-
ysis revealed that regulation of guanylyl cyclase plays a central
role in chemotactic signal transduction. Therefore, understand-
ing the detailed regulation of this enzyme may help to clarify
the mechanism of chemotaxis.
The present study started with the observation that non-
chemotactic mutants KI-4 and KI-7 have an aberrant cGMP
binding activity, and at the same time, show a strongly altered
cGMP response. These observations are intriguing, especially
from a genetic point of view, because the aberrant cGMP bind-
ing activity and altered cGMP response cannot be segregated
by parasexual analysis, suggesting that they are caused by the
same mutation or by closely linked mutations (8, 26). Particu-
late fractions from wild-type XP55 and mutant KI-4 and KI-7
cells contain comparable guanylyl cyclase activities. Therefore
these mutants are not defective in guanylyl cyclase itself but in
its regulation. The simplest explanation for this observation
would be that the cGMP-binding protein regulates guanylyl
cyclase activity. Since guanylyl cyclase from wild-type cells was
previously shown to be activated by a cytosolic protein (29) and
inhibited at conditions favoring protein kinase activity (30), we
have analyzed the regulation of guanylyl cyclase in mutants
KI-4 and KI-7.
The experiments investigating the stimulation of particulate
guanylyl cyclase by a cytosolic protein revealed the following
results. The cytosolic fraction from mutant KI-4 does not stim-
ulate particulate guanylyl cyclase activity. At the same time,
this mutant has an aberrant cGMP binding activity (abnormal-
ly low Kd) and shows a very small chemoattractant-mediated
cGMP response. DNA fragments, which are known to increase
cGMP binding activity (25), also stimulate guanylyl cyclase. In
mutant KI-4, both cGMP binding activity and guanylyl cyclase
activity are not influenced by DNA. Finally, the cGMP binding
activity and guanylyl cyclase-stimulating activity co-elute upon
chromatography of cytosolic proteins. These results strongly
support the hypothesis that guanylyl cyclase is activated
by a cytosolic cGMP-binding protein. Since the addition of
8-Br-cGMP, a potent ligand for the cGMP-binding protein, does
not affect the stimulation of guanylyl cyclase by the partially
purified activator, this implies that the cGMP occupancy of the
cGMP-binding protein is not a prerequisite for its stimulating
activity.
The addition of ATP to a cell homogenate inhibits guanylyl
cyclase activity, whereas the addition of a kinase inhibitor
ADPNHP or depletion of ATP by azide pretreatment enhances
guanylyl cyclase activity. The role of the cGMP-binding protein
in this ATP-mediated inhibition is suggested by the following
observations; guanylyl cyclase activity in the pellet is not af-
fected by ATP and inhibition by ATP requires the cytosol.
Furthermore, the inhibitory activity in the cytosol co-purifies
with the cGMP-binding protein. The cytosol of mutant KI-7,
which has an aberrant cGMP binding activity with abnormally
high Kd, does stimulate particulate guanylyl cyclase activity,
but ATP does not inhibit the enzyme. Interestingly, mutant
KI-7 shows a prolonged chemoattractant-mediated cGMP re-
sponse. Finally, the partially purified cGMP-binding protein
induces an ATP dose-dependent decrease of guanylyl cyclase
that is enhanced by the cGMP analog 8-Br-cGMP. This sug-
gests that cGMP stimulates ATP-mediated inhibition of gua-
nylyl cyclase.
In mammalian cells, two classes of guanylyl cyclase regula-
tors have been isolated. Guanylin regulates intestinal salt and
water transportation via the activation of guanylyl cyclase (for
review, see Ref. 33), whereas Ca21-sensitive proteins of the
recoverin family (guanylyl cyclase activating protein) activate
FIG. 4. Effect of ATP, ADPNHP, and azide pretreatment on
guanylyl cyclase activity in cell homogenates from XP55, KI-4,
and KI-7. Guanylyl cyclase activity was measured in cell homogenates
in the presence or absence of 1 mM ATP or 0.1 mM ADPNHP. The
activity was also measured in homogenates that were prepared from
cells pretreated with 10 mM azide for 5 min to deplete intracellular ATP
levels. Data are the means 6 S.D. of three (ATP and ADPNHP) or two
(azide) independent experiments with triplicate determinations.
FIG. 5. Effect of the cGMP analogue 8-Br-cGMP on the activa-
tion or ATP-mediated inhibition of guanylyl cyclase. Guanylyl
cyclase activity from XP55 was measured in a cell homogenate (T),
particulate fraction (P), or after reconstitution of the particulate frac-
tion with the partially purified cGMP-binding protein ( fra; mixture of
fractions 40, 41, and 42 in Fig. 2A). Guanylyl cyclase activity was
measured with or without the indicated ATP concentrations. Where
indicated, 50 nM 8-Br-cGMP was present during the reaction (8Br 1).
The concentration of ATP in the homogenate and the washed pellet is
calculated to be less than 14 and 2 mM, respectively. Guanylyl cyclase
activity is expressed as picomoles of cGMP formed per min per mg of
protein present in the original homogenate from which the particulate
fraction was obtained. The asterisk indicates that the addition of 8-Br-
cGMP induces a significant reduction of guanylyl cyclase activity rela-
tive to the incubation without 8-Br-cGMP (p , 0.01). cond., condition.
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guanylyl cyclase and are inhibited by Ca21 ions (34, 35). These
activators are not likely to be related to the cGMP-binding
protein in this study because they do not contain a consensus
cGMP-binding domain, and the estimated molecular mass of
the cGMP-binding protein (.80 kDa) is different from the two
activators (guanylin peptide consists of 15 amino acids; recov-
erin and guanylyl cyclase activating protein are 23 kDa). Dic-
tyostelium guanylyl cyclase is regulated by Ca21 ions in a way
that is very similar to the mammalian enzyme (28, 36). Mu-
tants KI-4 and KI-7 show normal inhibition by Ca21 (8), sug-
gesting that a functional cGMP-binding protein is not required
for the regulation of guanylyl cyclase by recoverin-like calcium-
binding proteins.
The combined results of the properties of the cGMP-binding
protein and the regulation of guanylyl cyclase in Dictyostelium
mutants KI-4 and KI-7 are complementary. The cGMP-binding
protein in KI-4 shows a very high affinity for cGMP, probably
because it is locked in a slow dissociating form of the protein. In
contrast, the cGMP binding activity in KI-7 has low affinity
and fast dissociation. The cytosol of mutant KI-4 can neither
stimulate nor inhibit guanylyl cyclase activity, whereas the
stimulation of guanylyl cyclase by the cytosol of mutant KI-7 is
normal and only inhibition is absent. These observations are in
perfect agreement with the chemoattractant-stimulated cGMP
responses in these mutants: the absence of guanylyl cyclase-
stimulating activity in KI-4 is associated with a very small
cGMP response, whereas the absence of the inhibitory activity
in KI-7 is correlated with a prolonged cGMP response.
Taken together, we propose that both the stimulation and
ATP-mediated inhibition of particulate guanylyl cyclase are
mediated by the cytosolic cGMP-binding protein. The results
are summarized in a model for the regulation of guanylyl
cyclase in vivo (Fig. 6). Chemoattractants stimulate guanylyl
cyclase via G-protein-coupled surface receptors. The associa-
tion of guanylyl cyclase with a cGMP-binding protein is neces-
sary for the maximal activation of the enzyme. This cGMP-
binding protein does not have to be occupied with cGMP;
therefore activation can start before guanylyl cyclase produces
cGMP. Once guanylyl cyclase is activated, the produced cGMP
binds to the binding protein and the occupied cGMP-binding
protein transduces the signal downstream to induce myosin
phosphorylation. The occupied cGMP-binding protein also re-
duces the activity of guanylyl cyclase in an ATP-dependent
manner, possibly via a protein kinase reaction. At this point,
two possibilities remain open: the stimulatory activity of the
cGMP-binding protein is converted to an inhibitory activity
upon occupancy of the cGMP-binding protein and presence of
ATP, or the stimulatory activity of the cGMP-binding protein is
lost in the presence of ATP. The observation that, in the pres-
ence of the partially purified cGMP-binding protein, ATP in-
hibits guanylyl cyclase activity to a level that is lower than the
enzyme activity in the particulate fraction favors the first pos-
sibility. The cGMP-binding protein may interact directly with
guanylyl cyclase, but it is also possible that other proteins bind
to the cGMP-binding protein and regulate both cGMP binding
activity and guanylyl cyclase activity. Such a more complex
regulation could explain the isolation of several mutants with
altered cGMP binding activity, which according to parasexual
genetics do not complement each other and are supposedly
mutated in different genes.
The model may explain how cells are able to locally retain
the information of a diffusible second messenger. For chemo-
taxis, a cell needs a sensing and transduction mechanism ca-
pable of discriminating between the sides of a cell with high
and low concentrations of chemoattractant. The present model
provides fast activation of guanylyl cyclase when associated
with the cGMP-binding protein, followed by the rapid inactiva-
tion of the enzyme when the produced cGMP binds to the
binding protein. The local activation of the cGMP-binding pro-
tein may induce the local phosphorylation of conventional my-
osin, leading to local pseudopodium formation. The absence of
chemotaxis in mutants KI-4 and KI-7 could be caused either by
the defective regulation of guanylyl cyclase by the cGMP-bind-
ing protein dislocalizing the intracellular cGMP signal or by
the inability of the cGMP-binding protein to transduce the
signal to downstream effectors, such as the phosphorylation of
conventional myosin.
Random mutagenesis of Dictyostelium cells has identified
nine chemotaxis mutants. Two mutants lack the chemoattrac-
tant-stimulated cGMP production, whereas four mutants show
an altered cGMP binding activity and aberrant fine regulation
of guanylyl cyclase. These mutants identify guanylyl cyclase
FIG. 6. Model of the regulation of guanylyl cyclase by a cGMP-binding protein. Guanylyl cyclase (GCase) is activated via a G-protein-
coupled cAMP chemoreceptor. The unoccupied form of the cGMP-binding protein (cGBP) is required for the optimal activation of guanylyl cyclase.
Upon binding of the produced cGMP to this binding protein (cGBP-cGMP), the binding protein negatively regulates guanylyl cyclase in an
ATP-dependent manner, possibly via a protein kinase. KI-4 is defective in both the positive and negative pathways, whereas KI-7 shows normal
activation but no ATP-dependent inhibition of guanylyl cyclase. The occupied cGMP-binding protein mediates the phosphorylation of conventional
myosin, finally leading to the formation of a local pseudopodium. In this model, the location of guanylyl cyclase is not properly drawn since it is
located on plasma membrane.
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and the cGMP-binding protein as two key components in the
processing of chemotactic signals in Dictyostelium.
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